The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKrm22 Plc Regulatory News (KRM)

Share Price Information for Krm22 Plc (KRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.50
Bid: 25.00
Ask: 30.00
Change: 0.00 (0.00%)
Spread: 5.00 (20.00%)
Open: 27.50
High: 27.50
Low: 27.50
Prev. Close: 27.50
KRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Fundraising

3 Apr 2019 07:00

RNS Number : 9089U
KRM22 PLC
03 April 2019
 

THIS ANNOUNCEMENT, INCLUDING THE INFORMATION CONTAINED HEREIN, IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. PLEASE SEE THE IMPORTANT NOTICES AT THE END OF THIS ANNOUNCEMENT.

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND SHALL NOT CONSTITUTE AN OFFER TO SELL OR ISSUE OR THE SOLICITATION OF AN OFFER TO BUY, SUBSCRIBE FOR OR OTHERWISE ACQUIRE ANY NEW ORDINARY SHARES OF KRM22 PLC IN THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL

 

KRM22 plc

 

("KRM22" or the "Company")

 

Fundraising

 

KRM22 plc, (AIM: KRM) the technology and software investment company that focuses on risk management for capital markets, is pleased to announce that it has conditionally raised gross proceeds of up to £1.8 million through a conditional placing of up to 1,601,318 new ordinary shares of 10 pence each in the Company ("Ordinary Shares") (the "Placing Shares") at a price of 85 pence per Ordinary Share (the "Issue Price") (the "Placing") and a subscription of up to 529,414 new Ordinary Shares (the "Subscription Shares" and together with the Placing Shares, the "Fundraising Shares") at the Issue Price (the "Subscription" together with the Placing, the "Fundraising").

 

Of the 1,601,318 Placing Shares, 129,412 have been conditionally placed with finnCap, and admission of these shares is subject to and conditional on an order being placed in the market by Fidelity Investments on behalf of Stephen Casner, Chief Executive Officer USA of the Company, to purchase the 129,412 Ordinary Shares at the Issue Price from finnCap. A further announcement will be made when appropriate.

 

Of the total 529,414 Subscription Shares, the subscribers for 235,295 of these Subscription Shares are completing the requisite subscription paperwork in order to complete their investments. Should this not complete by 30 April 2019, Keith Todd, Executive Chairman and CEO of the Company, has irrevocably undertaken to subscribe for those 235,295 Subscription Shares at the Issue Price in addition to his participation in the Placing as detailed below. A further announcement will be made when appropriate.

 

Application has been made for the remaining 1,471,906 Placing Shares, the remaining 294,119 Subscription Shares which have been placed firm and a further 117,647 new Ordinary Shares to be issued to certain advisers in lieu of fees (the "Adviser Shares") to be admitted to trading on AIM. Admission of those shares is expected to become effective on or around 5 April 2019 ("First Admission"). Following First Admission, KRM22 will have 18,260,060 Ordinary Shares in issue. All Ordinary Shares have equal voting rights and none of the Ordinary Shares are held in treasury. The total number of voting rights in the Company immediately following First Admission will therefore be 18,260,060.

 

Only once the order for 129,412 Ordinary Shares at the Issue Price from Fidelity Investments on behalf of Stephen Casner has been placed in the market and the trade with finnCap confirmed, application will be made for these 129,412 Placing Shares to be admitted to trading on AIM ("Second Admission"). Further details regarding Second Admission will be provided when appropriate.

 

Following confirmation of the remaining subscribers for the 235,295 Subscription Shares, application will be made for these shares to be admitted to trading on AIM ("Third Admission"). Further details regarding Third Admission will be provided when appropriate.

 

 

Details of the Fundraising

 

finnCap Ltd ("finnCap") acted as nominated adviser, broker and sole bookrunner in connection with the Placing. No part of the Placing is underwritten.

 

In accordance with the terms of a placing agreement entered into between the Company and finnCap, the Company has, via finnCap as placing agent, conducted a conditional placing to raise up to approximately £1.36 million by way of the issue of up to 1,601,318 Placing Shares at the Issue Price. In addition, the Company has raised up to approximately £0.45 million through the issue of up to 529,414 Subscription Shares at the Issue Price. Certain founders and Directors of the Company have subscribed for approximately £0.43 million pursuant to the Fundraising (including the proposed participation by Stephen Casner and assuming the 235,295 Subscription Shares are not subscribed for by Keith Todd).

The Placing Agreement is conditional, inter alia, upon:

a) the performance by the Company of its obligations under the Placing Agreement insofar as the same fail to be performed or satisfied on or prior to Admission (as defined below);

b) the Subscription in respect of the 294,119 Subscription Shares becoming unconditional in all respects, save for Admission; and

c) First Admission having occurred by 8.00 a.m. on 5 April 2019.

The Company continues to execute on its business plan and recently launched its Enterprise Risk Cockpit. The Company also remains in discussions with a pipeline of numerous investment targets in-line with its investment policy and partnerships to deliver applications on its Global Risk Platform.

The Company had identified three acquisition targets that it was actively pursuing, however the funding required to conclude these acquisitions has not been secured at this time. Subject to securing the debt finance, details of which are outlined below, the Company intends to continue to pursue two of the three acquisition targets. The net proceeds of the Fundraising are being used for the general working capital requirements of the Company and its existing businesses.

Since admission of the Company's shares to trading on AIM in April 2018, the Company has accelerated the development of the Global Risk Platform and Risk Cockpit. As a direct result it has been able to launch its proprietary Enterprise Risk Cockpit in March 2019. This area of the business has required a substantial amount of capital allocated to development and marketing of this core product. In addition to this, the Company expanded its infrastructure to scale up to capitalise on the many investment opportunities identified at the time of the listing. As a result, the Company has made a number of advantageous investments and partnerships in the period with the integration substantially complete. Given these milestones, the Company will now be focusing on its existing business as well as securing new partnerships to add to the existing footprint and as a result, the Company has reduced overhead costs to reflect the size and focus of the business today.

In addition to the Fundraising, the Company is pursuing discussions with alternative sources of funding including strategic partnerships and debt funding to support the Company's investment policy. The Company is in preliminary discussions with a venture debt provider for a facility of up to £10.0 million of which an initial £1-2.5 million will be drawn down on completion or shortly thereafter. The balance of the facility will become available in tranches conditional on the Company's rate of recurring revenues, which would include acquired recurring revenue. The interest rate payable pursuant to this facility is in the range of 10-12 per cent. and the proposed arrangement also includes the issue of a warrant over a number of Ordinary Shares with a value equal to a maximum of £1.0 million of which 50 per cent. would be issued upon the initial draw down. There can be no certainty that these discussions will result in additional new funding for the Company however, the Directors remain confident of concluding these arrangements. Should the Company be successful in obtaining appropriate financing, the Company will then actively pursue the pipeline of investment targets.

The two potential acquisitions under consideration, which are subject to the above outlined debt funding being agreed, are both based in the US and provide risk management software within the Market Risk domain. Together they would provide the Company with an aggregate c.$2.0m of annual recurring revenue and an additional 29 customers and are both breakeven at the profit level. The total consideration payable for each acquisition would comprise an initial consideration (of which an aggregate of c.£0.8m would be payable in cash) and an earn-out consideration payable in cash and shares. The total consideration payable would be between 2-3x annual recurring revenues, in-line with the Directors' expectations at the time of the IPO in April 2018. Further details will be provided once the proposed debt funding is agreed and negotiations with the vendors finalised. There can be no assurance at this time that both or either acquisition will complete.

The Issue Price represents a discount of approximately 3.4 per cent. to the closing mid-market price of the Ordinary Shares of 88 pence on 1 April 2019 (being the last practicable dealing day prior to the date of this announcement).

The 1,883,672 new Ordinary Shares to be issued upon First Admission will represent approximately 10.32 per cent. of the enlarged issued share capital of the Company following First Admission and will rank pari passu in all other respects with the Company's existing Ordinary Shares.

The Fundraising Shares are being issued pursuant to the authorities granted to the Directors at the general meeting held by the Company on 21 January 2019 and as such, the issuance of the Fundraising Shares is not subject to shareholder approval.

 

Related Party Transactions

 

Keith Todd and persons closely associated with him have subscribed for an aggregate of 235,296 new Ordinary Shares at the Issue Price. Following this subscription, Keith Todd will have a beneficial interest in 1,775,296 Ordinary Shares in the Company, representing approximately 9.72 per cent. of the enlarged issued share capital on First Admission. Should the subscribers (as described above) not participate in the Subscription by 30 April 2019, Keith Todd has irrevocably undertaken to acquire a further 235,295 new Ordinary Shares at the Issue Price. Following this additional subscription, Keith Todd would have a beneficial interest in 2,010,591 Ordinary Shares in the Company, representing approximately 10.80 per cent. of the enlarged issued share capital assuming First, Second and Third Admission.

Sandy Broderick, Non-Executive Director of the Company, has subscribed for an aggregate of 11,765 new Ordinary Shares at the Issue Price. Following this subscription, Sandy will have a beneficial interest in 11,765 Ordinary Shares in the Company, representing approximately 0.06 per cent. of the enlarged issued share capital on First Admission.

As described above, Stephen Casner will acquire 129,412 of the Placing Shares at the Issue Price shortly following First Admission. These 129,412 Placing Shares have been conditionally placed with finnCap and admission of these shares is subject to and conditional on an order being placed in the market by Fidelity Investments on behalf of Stephen Casner, to purchase the 129,412 Ordinary Shares at the Issue Price from finnCap. Following this intended acquisition, Stephen Casner will have a beneficial interest in 636,555 Ordinary Shares in the Company representing 3.46 per cent. of the enlarged issued share capital on Second Admission.

Keith Todd, Stephen Casner and Sandy Broderick are considered "related parties" as defined under the AIM Rules due to their Board positions. Keith Todd, Stephen Casner and Sandy Broderick's participations in the Fundraising constitute related party transactions for the purposes of Rule 13 of the AIM Rules.

In addition, Canaccord Genuity ("Canaccord"), has subscribed for 352,942 new Ordinary Shares at the Issue Price. Following this subscription, Canaccord will in aggregate hold 2,796,585 Ordinary Shares in the Company (including its shares held by Hargreave Hale AIM VCT and Canaccord Wealth), representing approximately 15.32 per cent. of the enlarged issued share capital on First Admission.

Canaccord is considered a "related party" as defined under the AIM Rules as a result of its substantial shareholding in the Company. Canaccord's participation in the Placing constitutes a related party transaction for the purposes of Rule 13 of the AIM Rules.

The Independent Directors (being the Directors of the Board, other than Keith Todd, Stephen Casner and Sandy Broderick) consider, having consulted with the Company's nominated adviser for the purposes of the AIM Rules, finnCap, that the terms of Keith Todd's, Stephen Casner's and Sandy Broderick's and Canaccord's subscription for shares fair and reasonable insofar as the Company's shareholders are concerned.

 

Keith Todd, Executive Chairman and CEO of the Company, commented:

"The past months have validated the KRM22 business proposition and we are well placed to continue our development and growth supported by this fund raising."

 

 

For further information please contact:

 

 

KRM22 plc

via FTI Consulting LLP

Keith Todd CBE, Executive Chairman and CEO

 

Karen Bach, COO

 

 

 

finnCap Ltd (Nominated Adviser and Sole Broker)

+44 (0)20 7220 0500

Carl Holmes / Kate Bannatyne - Corporate Finance

 

Alice Lane / Sunila de Silva - ECM

 

 

 

FTI Consulting LLP

+44 (0)20 3727 1000

Matt Dixon / Jamille Smith / Debbie Oluwaseyi Sonaike

 

 

 

About KRM22 plc

KRM22 is a closed-ended investment company which listed on AIM on 30 April 2018. The Company has been established with the objective of creating value for its investors through the investment in, and subsequent growth and development of, target companies in the technology and software sector, with a focus on risk management in capital markets.

 

Through its investments and the Global Risk Platform, KRM22 helps capital market companies reduce the cost and complexity of risk management - a fundamental challenge that erodes their profitability and constrains opportunities to generate alpha.

 

Through the KRM22 Global Risk Platform, KRM22 offers a modular application portfolio addressing risk management challenges across risk domains, covering market, regulatory, technology and operations risk, and across these domains as enterprise risk to assess, monitor and manage the increasing correlation between them.

 

Capital markets companies' partner with KRM22 to optimize risk management systems and processes to improve profitability and expand opportunities to increase portfolio returns by successfully leveraging risk as alpha.

KRM22 PLC is listed on AIM and the Group is headquartered in London, with offices in several of the world's major financial centres.

 

See more about KRM22 at KRM22.com.

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

IMPORTANT NOTICES

This announcement should be read in its entirety. In particular, you should read and understand the information provided in this "Important Notices" section of this announcement.

This announcement does not constitute a prospectus for the purposes of the Prospectus Rules of the FCA, nor does it comprise an admission document prepared in accordance with the AIM Rules. Accordingly, this announcement has not been approved by or filed with the FCA.

finnCap, which is authorised and regulated in the United Kingdom by the FCA, is acting as nominated adviser, broker and sole bookrunner to the Company for the purposes of the AIM Rules exclusively for the Company and no one else and will not be responsible to any other person for providing protections afforded to their customers nor for providing advice in relation to the contents of this announcement. No representation, warranty, express or implied, is made by finnCap for the accuracy of any information or opinions contained in this announcement or the omission of any material information, nor has finnCap authorised the contents of this announcement for any purpose and no liability whatsoever is accepted by finnCap. finnCap expressly disclaims all and any responsibility or liability whether arising in tort, contract or otherwise which they might otherwise have in respect of this announcement.

 Forward-Looking Statements

This announcement contains forward-looking statements. These statements relate to the Group's future prospects, developments and business strategies. Forward-looking statements are identified by their use of terms and phrases such as "potential", "estimate", "expect", "may", "will" or the negative of such terms and phrases, variations or comparable expressions, including references to assumptions. The forward-looking statements in this announcement are based on current expectations and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by those statements. These forward-looking statements speak only as at the date of this announcement. No statement in this announcement is intended to constitute a profit forecast or profit estimate for any period. Neither the Directors nor the Company undertake any obligation to update forward-looking statements other than as required by the AIM Rules or by the rules of any other securities regulatory authority, whether as a result of new information, future events or otherwise.

FUNDRAISING STATISTICS

 

Existing issued share capital

16,376,388

Issue Price

85 pence

Placing Shares to be issued at the Issue Price upon First Admission

1,471,906

Placing Shares at be issued at the Issue Price upon Second Admission

up to 129,412

Subscription Shares to be issued at the Issue Price upon First Admission

294,119

Subscription Shares to be issued at the Issue Price upon Third Admission

up to 235,295

Total Fundraising Shares

up to 2,130,732

Adviser Shares to be issued at the Issue Price*

117,647

Enlarged issued share capital following First Admission

18,260,060

Enlarged issued share capital following Second Admission**

18,389,472

Enlarged issued share capital following Third Admission***

18,624,767

Percentage of enlarged issued share capital being placed pursuant to the Fundraising (following Third Admission***)

up to 11.44%

Gross proceeds of the Fundraising

up to £1.81 million

Market Capitalisation of the Company at First Admission at the Issue Price

£15.52 million

 

* Adviser Shares means the 47,059 and 70,588 new Ordinary Shares to be issued to finnCap Ltd and Fieldfisher LLP, respectively, at the Issue Price in lieu of fees payable by the Company to such advisers in relation to the Fundraising

** Assuming the full 129,412 Placing Shares are issued pursuant to Second Admission

*** Assuming the full 235,295 Subscription Shares are issued pursuant to Third Admission

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEITMRTMBBMBIL
Date   Source Headline
16th Apr 20247:00 amRNSDirector Dealings
15th Apr 20247:00 amRNSNew Customer Contract
10th Apr 20247:00 amRNSIssue of Equity
7th Mar 20247:00 amRNSBoard Changes
21st Feb 20247:00 amRNSTrading Update
1st Dec 20237:00 amRNSIssue of Restricted Stock Units
26th Sep 20237:00 amRNSInterim Results
27th Jul 202311:48 amRNSResult of General Meeting
21st Jul 20237:00 amRNSDirector Dealing
20th Jul 20237:00 amRNSHalf Year Trading Update
4th Jul 20237:00 amRNSPosting of Accounts, Circular and Notice of GM
30th Jun 202312:41 pmRNSResult of AGM
27th Jun 20237:00 amRNSFinal Results
19th Jun 20237:00 amRNSNew Debt Facility
8th Jun 20237:00 amRNSAnnual Report and Notice of AGM
16th Dec 20223:15 pmRNSIssue of Options
20th Sep 20227:00 amRNSInterim Results
13th Jun 202210:00 amRNSHolding(s) in Company
5th May 202212:00 pmRNSResult of AGM
20th Apr 20222:30 pmRNSDirector Dealing
12th Apr 20227:00 amRNSNotice of AGM and Posting of Annual Report
7th Apr 20224:30 pmRNSHolding(s) in Company
28th Mar 20225:30 pmRNSHolding(s) in Company
23rd Mar 20227:00 amRNSFinal Results
15th Mar 20227:00 amRNSProduct Launch Under Distribution Agreement
1st Mar 20227:00 amRNSUpdate re Annual Results (Change of Date)
31st Jan 20227:00 amRNSTrading Update
5th Jan 202210:47 amRNSHolding(s) in Company
30th Dec 20219:47 amRNSSubscription Completion, Executive Changes and TVR
22nd Dec 20217:00 amRNSSubscription Update
22nd Nov 20217:00 amRNSHolding(s) in Company
1st Nov 20217:00 amRNSSubscription Agreement and Trading Update
20th Oct 20213:43 pmRNSHolding(s) in Company
16th Sep 20212:38 pmRNSDirector/PDMR Shareholding
13th Sep 20219:52 amRNSDirector/PDMR Shareholding
10th Sep 20212:48 pmRNSDirector/PDMR Shareholding
8th Sep 202112:00 pmRNSDirector/PDMR Shareholding
2nd Sep 20217:00 amRNSDirector/PDMR Shareholding
1st Sep 20217:00 amRNSInterim Results
30th Jul 20217:00 amRNSContract Extension
22nd Jul 20217:00 amRNSHalf Year Trading Update
24th Jun 20217:00 amRNSKRM22 announces partnership with Waymark Tech
28th Apr 20211:29 pmRNSResult of AGM
19th Apr 20217:00 amRNSExercise of options and total voting rights
26th Mar 20213:24 pmRNSHolding(s) in Company
23rd Mar 20218:00 amRNSNotice of AGM and Posting of Annual Report
18th Mar 20215:39 pmRNSHolding(s) in Company
16th Mar 202111:06 amRNSTechnology Demonstration
16th Mar 20217:00 amRNSFinal Results
24th Feb 20217:00 amRNSKRM22 announces new partnership

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.